论文部分内容阅读
目的:讨论西医治疗冠心病稳定型心绞痛系统评价。方法:采取计算机检索的方式对其近几年关于西医治疗冠心病稳定型心绞痛的文献作为相应的对照研究,根据排除以及纳入的标准对其文献进行选择,并对其相关的资料进行提取以及质量评价,再RevMan 5.0软件进行处理。结果:曲美他嗓的临床疗效明显高于其余对照组,在运动持续时间、心绞痛发作频率、药物的使用量(硝酸甘油)、心绞痛发作阈值以及ST段压低1mm阈值上表,具有明显的优势,组间数据差异明显,数据差异具有统计学意义(P<0.1)。曲美他嗪组与对照组在不良反应上比较,则无明显的差异,数据差异无统计学意义(P>0.1)。结论:曲美他嗪联合常规治疗冠心病稳定型心绞痛的临床疗效好,且具有较高的安全性,具有在临床上广泛推广的价值。本次选择的文献可能存在着一定的偏差,其结论还需进行进一步的证实。
Objective: To discuss the western medicine treatment of coronary heart disease stable angina pectoris system. Methods: To take the computerized retrieval method as the corresponding control study on western medicine in the treatment of patients with stable angina pectoris in recent years, select its literature according to the criteria of exclusion and inclusion, and extract the related information and the quality Evaluation, then RevMan 5.0 software for processing. Results: The clinical efficacy of trimethoprim thymus was significantly higher than that of the control group. The duration of exercise, the frequency of angina attacks, the dosage of drugs (nitroglycerin), the threshold of angina pectoris and the 1 mm threshold of ST segment depression were significantly superior , There was significant difference between the two groups of data, the data difference was statistically significant (P <0.1). Trimetazidine group and control group in the adverse reactions, there was no significant difference, the data was no significant difference (P> 0.1). Conclusion: Trimetazidine combined with conventional treatment of coronary heart disease with stable angina pectoris has good clinical curative effect, high safety and wide clinical value. The choice of the literature there may be some deviation, the conclusion needs further confirmation.